Novartis AG announced that it has successfully completed its acquisition of Avidity Biosciences, Inc. With the completion of the acquisition, Avidity is now an indirect, wholly owned subsidiary of Novartis. “Avidity’s breakthrough science combined with Novartis capabilities will help reimagine what’s possible for pe…
GSK plc announced the completion of its previously announced acquisition of RAPT Therapeutics, a California-based, clinical-stage biopharmaceutical company dedicated to developing novel therapies for patients living with inflammatory and immunologic diseases. The acquisition includes ozureprubart, a long-acting anti…
Insilico Medicine and Liquid AI announced a partnership that creates lightweight scientific foundation models for pharmaceutical research. The collaboration has produced LFM2-2.6B-MMAI (v0.2.1), available now – a single checkpoint trained to perform at state-of-the-art levels across multiple drug discovery subdomains,…
WuXi XDC Cayman , a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates (ADCs) and other bioconjugates, today announced a strategic collaboration with Earendil Labs on WuXi XDC's proprietary WuXiTecan-2 payload-linker technology platform. Earen…
IQVIA Holdings, a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, announced it has entered into an agreement to acquire certain discovery services assets from Charles River Laboratories. The acquisition complements IQVIA Laboratories’ e…
Earendil Labs, a global leader in AI-driven research and development of next-generation biologics therapeutics, announced a strategic collaboration with WuXi XDC Cayman Inc. on WuXi XDC's proprietary WuXiTecan-2 payload-linker technology platform. WuXi XDC Cayman Inc. is a globally recognized contract research, develo…
Hangzhou Sciwind Biosciences Co., Ltd. announced a strategic commercialization collaboration with Pfizer China for Ecnoglutide injection (Ecnoglutide), a new–generation cAMP–biased GLP–1 receptor agonist. Under the agreement, Pfizer will obtain exclusive commercialization rights for the product in Mainland China, mark…
Bora Pharmaceuticals Co., Ltd., a global leader in pharmaceutical manufacturing, and have signed a strategic agreement to renew a five-year manufacturing partnership. Bora purchased the Mississauga facility from GSK in 2020. This renewed collaboration reinforces the long-standing relationship between the two companies…
Astellas Pharma Inc. and Vir Biotechnology, Inc. announced they have entered into a global strategic collaboration to advance VIR-5500, an investigational PRO-XTEN® dual-masked CD3 T-cell engager (TCE) targeting PSMA for the treatment of prostate cancer. The collaboration aims to accelerate the development of VIR-5500…
Danaher Corporation, a global science and technology innovator, announced that it has entered into a definitive agreement to acquire Masimo Corporation a leading specialty diagnostics provider of pulse oximetry and other patient monitoring solutions, primarily in acute care settings. Under the terms of the agreement, …
Page 14 of 36